[1] Morton L M, Turner J J, Cerhan J R, et al. Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph).[J]. Blood, 2007, 110(2):695-708.
[2] Anderson K C, Alsina M, Bensinger W, et al. Waldenstrom's macroglobulinemia/lymphoplasmacytic lymphoma, version 2.2013.[J]. Journal of NCCN, 2012, 10(10):1211.
[3] 祁 健,陈 晨,王荣梅.利妥昔单抗引起肝功能损害1例[J].中国医院药学杂志,2017,(9):892-893.
[4] 陈 永,高永艳,李 艳, 等.利妥昔单抗致不良反应325例文献分析[J].广东药学院学报,2010,26(2):179-181.
[5] Todd D J, Helfgott S M. Serum sickness following treatment with rituximab[J]. Journal of Rheumatology, 2007, 34(2):430-433.
[6] Heresi G A, Farver C F, Stoller J K. Interstitial pneumonitis and alveolar hemorrhage complicating use of rituximab: case report and review of the literature[J]. Respiration, 2007, 76(4):449-453.
[7] 赵 敏,张秀红.利妥昔单抗引起过敏反应2例[J].药物不良反应杂志,2010,12(1):58-59.